Bridgefront Capital’s Acceleron Pharma XLRN Stock Holding History

Bridgefront Capital’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,232	Closed	-$212K	–	490
2021 Q3	$212K	Buy	+1,232	New	+$161K	0.22%	235

Bridgefront Capital's XLRN Position: Q4 2021 in Review

Bridgefront Capital sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,232 shares — an estimated $212K sold.

Bridgefront Capital first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $212K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Bridgefront Capital reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Bridgefront Capital sold 1,232 Acceleron Pharma shares in Q4 2021, an estimated $212K.
Bridgefront Capital first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Bridgefront Capital's Acceleron Pharma position peaked at $212K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bridgefront Capital's 13F filing for Q4 2021, filed 10 Feb 2022.